Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting
April 10, 2025 16:05 ET | Source: Protara Therapeutics NEW YORK, April…
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
April 07, 2025 17:21 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass.,…
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq:…
The Ensign Group Adds Two Operations in California
April 02, 2025 06:00 ET | Source: The Ensign Group, Inc. SAN…
Empowering Relief Efforts: Iridium Partners with World Central Kitchen
MCLEAN, Va., March 12, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM) a…
Arcutis to Present Two Posters at the 83rd American Academy of Dermatology Annual Meeting
One poster will share pooled INTEGUMENT data of ZORYVE® (roflumilast) cream 0.15%…
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
WESTLAKE VILLAGE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq:…
nCino Announces Timing of its Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call
February 17, 2025 07:40 ET | Source: nCino, Inc. WILMINGTON, N.C., Feb.…
BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific Sessions
SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. today announced…